Integrated Biochemical and Computational Evaluation of Bis-Imidazolium Derivatives 3e–3g in Cholinesterase and HIV-1 Reverse Transcriptase Assays
Molecules · 06.11.2026 · 31 (21) · 4006
DOI: 10.3390/molecules31214006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 06.11.2026. Verfasst von Edanur Altuntas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon 61080, Turkey. Hauptthemen laut MEDLINE: HIV Reverse Transcriptase, Cholinesterase Inhibitors, Imidazoles, Reverse Transcriptase Inhibitors. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karadeniz Technical University, Karadeniz Technical University Scientific Research Projects Unit.
Abstract (Originalsprache)
Bis-imidazolium derivatives (3e, 3f, 3g) were evaluated for their inhibitory activity against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) using colorimetric assays and molecular docking. For the HIV-1 RT–3e complex, a 100 ns molecular dynamics (MD) simulation and Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) analysis were performed. Compound 3e emerged as the most active derivative, showing the lowest half-maximal inhibitory concentration (IC50) values: 13.36 µg/mL for AChE, 4.95 µg/mL for BChE, and 50.44 µg/mL for HIV-1 RT. Nevirapine produced 95.33% RT inhibition at 20 µM. Redocking validated the binding poses with root-mean-square deviation (RMSD) values below 2.0 Å, though docking scores lacked consistent correlation with experimental activity rankings. In the MD trajectory, 3e remained stable within the RT binding pocket, yielding an MM/GBSA energy of −51.04 ± 8.39 kcal/mol. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) predictions indicated low gastrointestinal absorption, no blood–brain barrier permeation, and a high-confidence human ether-à-go-go-related gene (hERG) potassium channel blockade alert. These findings highlight 3e for further optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon 61080, Turkey.
- Department of Molecular Biology and Genetics, Graduate Institute of Natural and Applied Sciences, Karadeniz Technical University, Trabzon 61080, Turkey.
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon 61080, Turkey.
ORCID-Profile: Aleyna Nalcaoglu Senocak, Halil Ibrahim Guler
Förderung
- Karadeniz Technical University
- Karadeniz Technical University Scientific Research Projects Unit
Zitieren
APA
Altuntas, E., Senocak, A. N., Ünver, Y., & Guler, H. I. (2026). Integrated Biochemical and Computational Evaluation of Bis-Imidazolium Derivatives 3e–3g in Cholinesterase and HIV-1 Reverse Transcriptase Assays. Molecules, 31(21), 4006. https://doi.org/10.3390/molecules31214006
Vancouver
Altuntas E, Senocak AN, Ünver Y, Guler HI. Integrated Biochemical and Computational Evaluation of Bis-Imidazolium Derivatives 3e–3g in Cholinesterase and HIV-1 Reverse Transcriptase Assays. Molecules. 2026;31(21):4006. doi:10.3390/molecules31214006
BibTeX
@article{Altuntas2026,
author = {Altuntas, Edanur and Senocak, Aleyna Nalcaoglu and Ünver, Yasemin and Guler, Halil Ibrahim},
title = {Integrated Biochemical and Computational Evaluation of Bis-Imidazolium Derivatives 3e–3g in Cholinesterase and HIV-1 Reverse Transcriptase Assays},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {4006},
doi = {10.3390/molecules31214006}
}
EUVIMED